Výsledky vyhledávání - "Maryam Nabavifard"

Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy

Autor: Babak PeyroShabany, Mansoureh Dehghani, Seyed Alireza Javadinia, Danial Fazilat-Panah, Pejman Porouhan, Farbod Hatami, James S Welsh, Maryam Nabavifard, Mona Ariamanesh, Mohammad Fereidouni

Publikováno v: Cancer Investigation
article-version (VoR) Version of Record

ObjectivePatients with malignancy suffer from a compromised immune system due to either the effects of malignancies or treatments. Cancer patients are at higher risk of different infections particularly SARS-CoV2 and usually produce weaker response t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21df361b8c9524109f7fc850a9c25c60
https://doi.org/10.1080/07357907.2021.1992420

Zobrazit plný text záznamu

Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic

Autor: Mansoureh Dehghani, Pejman Porouhan, Mona Ariamanesh, Farbod Hatami, Somayeh Ashkar Tizabi, Gary H. Lyman, Babak PeyroShabany, James S Welsh, Seyed Alireza Javadinia, Maryam Nabavifard, Danial Fazilat-Panah, Ahmad Ghasemi

Publikováno v: Cancer investigation. 40(2)

Patients with cancer are at significantly greater risk of COVID-19 and its complications than the general population. Since IgG antibodies remain detectable well after infection with the SARS-CoV-2 virus, seroprevalence can be used to estimate the pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d21523637ee7a51b64bdc1543be2b1ab
https://pubmed.ncbi.nlm.nih.gov/34699294

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání